AU575951B2 - Insulin preparation with thickening agent and surfactant - Google Patents

Insulin preparation with thickening agent and surfactant

Info

Publication number
AU575951B2
AU575951B2 AU43424/85A AU4342485A AU575951B2 AU 575951 B2 AU575951 B2 AU 575951B2 AU 43424/85 A AU43424/85 A AU 43424/85A AU 4342485 A AU4342485 A AU 4342485A AU 575951 B2 AU575951 B2 AU 575951B2
Authority
AU
Australia
Prior art keywords
plunger pipe
plate
damper
sealing plate
pipe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU43424/85A
Other versions
AU4342485A (en
Inventor
Ulrich Grau
Dietrich Hiller
Horst Paul Neubauer
Gerhard Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/en
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU4342485A publication Critical patent/AU4342485A/en
Application granted granted Critical
Publication of AU575951B2 publication Critical patent/AU575951B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Abstract

1. Pulsation damper (10) for elastically disposed objects (26), including a damper housing which is at least partially filled with 3 viscose damping medium (12) and which is open at the top relative to its installation position ; a hollow plunger pipe (17) which is open at the bottom relative to its installation position and continuously conically formed and which can be moved up and down into the damper medium (12) ; a top plate (16), linked with the plunger pipe (17), for receiving the object (26), in which respect the plunger pipe (17) is connected with the top plate (16) by its smaller diameter (28), and its larger diameter (29) is emersed into the damper medium (12), characterised in that the interior of the plunger pipe (17) is divided into two chambers by a sealing plate (22) ; that a buffer plate (24) including passages (33) is disposed in the larger diameter (29) at the bottom of the plunger pipe (17) which plate carries a plurality of interior pipes (21) which extend into the plunger pipe (17), the upper ends of the interior pipes (21) being at a distance (35) from the sealing plate (22), and the plunger pipe (17) has a plurality of peripheral bores (19) in the casing surface below the sealing plate (22).
AU43424/85A 1984-06-09 1985-06-07 Insulin preparation with thickening agent and surfactant Expired AU575951B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3421615 1984-06-09
DE3421615 1984-06-09
DE3421613 1984-06-09
DE3421613 1984-06-09
DE3443877 1984-12-01
DE19843443877 DE3443877A1 (en) 1984-06-09 1984-12-01 Insulin preparations, process for their preparation, and their use

Publications (2)

Publication Number Publication Date
AU4342485A AU4342485A (en) 1985-12-12
AU575951B2 true AU575951B2 (en) 1988-08-11

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43424/85A Expired AU575951B2 (en) 1984-06-09 1985-06-07 Insulin preparation with thickening agent and surfactant

Country Status (16)

Country Link
EP (1) EP0166971B1 (en)
AT (1) ATE50502T1 (en)
AU (1) AU575951B2 (en)
CA (1) CA1258427A (en)
DE (1) DE3576120D1 (en)
DK (1) DK162255C (en)
ES (1) ES8605679A1 (en)
FI (1) FI80596C (en)
GR (1) GR851393B (en)
HU (1) HU200102B (en)
IE (1) IE57998B1 (en)
IL (1) IL75448A (en)
NO (1) NO164277C (en)
NZ (1) NZ212338A (en)
PH (1) PH24118A (en)
PT (1) PT80620B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179479C (en) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Process for the preparation of an intravaginal pharmaceutical preparation
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
DE10227232A1 (en) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Sour insulin preparations with improved stability
PT3228320T (en) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combination of an insulin and a glp-1 agonist
US10029011B2 (en) 2009-11-13 2018-07-24 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
PT2498801T (en) 2009-11-13 2018-05-02 Sanofi Aventis Deutschland Pharmaceutical composition comprising despro36exendin-4(1-39)-lys6-nh2 and methionine
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (en) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
JP6457484B2 (en) 2013-04-03 2019-01-23 サノフイSanofi Treatment of diabetes with long-acting insulin preparations
NZ733670A (en) 2014-12-12 2021-12-24 Sanofi Aventis Deutschland Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4292585A (en) * 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch
AU549981B2 (en) * 1982-02-05 1986-02-20 Novo Nordisk A/S Zinc stabilized insulin
AU552054B2 (en) * 1981-08-27 1986-05-22 Eli Lilly And Company Human proinsulin compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (en) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Method of treating diabetes mellitus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU552054B2 (en) * 1981-08-27 1986-05-22 Eli Lilly And Company Human proinsulin compositions
AU549981B2 (en) * 1982-02-05 1986-02-20 Novo Nordisk A/S Zinc stabilized insulin
AU4292585A (en) * 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
EP0166971A1 (en) 1986-01-08
HUT37893A (en) 1986-03-28
IE851431L (en) 1985-12-09
PT80620B (en) 1987-10-20
GR851393B (en) 1985-11-25
NZ212338A (en) 1989-02-24
FI852273A0 (en) 1985-06-06
AU4342485A (en) 1985-12-12
IE57998B1 (en) 1993-06-02
IL75448A0 (en) 1985-10-31
HU200102B (en) 1990-04-28
FI80596B (en) 1990-03-30
NO164277C (en) 1990-09-19
NO852314L (en) 1985-12-10
NO164277B (en) 1990-06-11
DK254585D0 (en) 1985-06-06
ATE50502T1 (en) 1990-03-15
DK162255C (en) 1992-03-16
PH24118A (en) 1990-03-05
PT80620A (en) 1985-07-01
DE3576120D1 (en) 1990-04-05
FI852273L (en) 1985-12-10
ES543972A0 (en) 1986-01-16
IL75448A (en) 1989-07-31
CA1258427A (en) 1989-08-15
EP0166971B1 (en) 1990-02-28
ES8605679A1 (en) 1986-01-16
DK254585A (en) 1985-12-10
FI80596C (en) 1990-07-10
DK162255B (en) 1991-10-07

Similar Documents

Publication Publication Date Title
AU575951B2 (en) Insulin preparation with thickening agent and surfactant
JPS646543A (en) Vibration isolating device
JPS57191127A (en) Engine mount filled with fluid
ES8608163A1 (en) Apparatus for the cryofixation of specimens.
PT823288E (en) MINIATURE PUMP STATION MOUNTING SYSTEM IN A SMALL CAPACITY RESERVOIR
JPS57173663A (en) Connecting piece with sealed ring
DE59906300D1 (en) Fluid shock absorber
DE3664298D1 (en) Energy absorbers
JPS57127141A (en) Multi-direction vibration-proof device
ES2048369T3 (en) LIQUID METAL TREATMENT.
JPS57100225A (en) Attachment for driving pile for breaker
ATE43384T1 (en) PIPE SEPARATOR.
JPS5576238A (en) Automobile damper
ES257901U (en) Tomamuestras head for blood sedimentation speed meter. (Machine-translation by Google Translate, not legally binding)
CA2226551A1 (en) Sealing and guiding device for the injection piston of a hot chamber pump for corrosive alloys
IT1235157B (en) Suspension in a rubber sleeve with hydraulic dampening, in particular for machine parts
JPS56143842A (en) Damper
DE3273037D1 (en) Horizontal chamber coke oven
IT1244222B (en) Siphon for passage of fluids from streams with free surfaces and streams under pressure
ES262731U (en) Support of motor of two cameras with hydraulic amortiguación. (Machine-translation by Google Translate, not legally binding)
UA39943C2 (en) ENERGY COMPENSATOR
JPS5532289A (en) Stabilizer of up and down movement for pick up cartridge